CDG Invest Growth invests in the capital of companies in Morocco and Africa

CDG Invest Growth announces the exit of Capmezzanine III Fund from Soludia Maghreb, a key player in the manufacturing of hemodialysis products in Morocco

Decembre 17, 2025 — CDG Invest Growth announces the exit of Capmezzanine III Fund from Soludia Maghreb, a key player in the manufacturing of hemodialysis products in Morocco. This transaction consists in Sothema’s strategic acquisition of 99.99% of Soludia Maghreb’s share capital and voting rights.

Founded in 1998, Soludia Maghreb is a pharmaceutical company specializing in the manufacturing of hemodialysis concentrates and the distribution of pharmaceutical products and medical devices sourced from international laboratories.

CDG Invest Growth joined Soludia Maghreb’s shareholding structure in December 2021 and supported the company in the execution of its development projects, including the upgrade of its industrial platform, the diversification of its product offering into new products and therapeutic areas, the strengthening of its sales force, its geographic expansion, and its development through external growth.

This transaction marks the successful completion of a close partnership with Soludia Maghreb during key phases of its development and results in a smooth transition to Sothema Group, opening a new phase of growth for the company.

Hassan Laaziri, CEO of CDG Invest Growth, stated:

“This transaction reflects the successful partnership between CDG Invest Growth and Soludia Maghreb, built on the strengthening of the company’s operational fundamentals and the acceleration of its growth trajectory. The handover to a leading industrial player such as Sothema represents a major milestone and opens up enhanced industrial and commercial development prospects for Soludia Maghreb.”

CDG Invest Growth was advised in this transaction by DLA Piper (legal counsel)

CDG Invest Growth has signed an agreement to acquire a minority stake in l’Assiette Nordique, a leading seafood processing and distribution company in Morocco. The transaction will be executed through Capmezzanine V FPCC-RFA, CDG Invest Growth’s fifth fund under management, and remains subject to Antitrust Clearance. The transaction, completed through a capital increase, represents a […]

29 July 2021 CDG Invest Growth (“CIG”), the leading Morocco based private equity firm previously known as CDG Capital Private Equity, and Techniques Science-Santé (“T2S”), IM Alliance, Cyclopharma and Binarios (together, the “Company” or the “Group”) are pleased to announce the signing of an agreement for the sale of a majority stake in the largest […]

At an investment return of 4.6 money multiple, CDG Invest Growth has announced its successful exit from regional outsourcing company Intelcia, in favor of Altice group, a multinational group operating in telecommunications, content and media. « CDG Invest Growth has strongly contributed to Intelcia’s growth in Morocco and globally and has enhanced corporate governance culture » said […]